Back to today’s briefing

Story perspectives

Study Boosts Mice Lifespan by Up to 35%

5/29/2025

45 9

Summary

Story summary

A groundbreaking study by scientists at the Max Planck Institute reveals that a drug cocktail of rapamycin and trametinib significantly boosts mice lifespans by 26-35%. This powerful combination not only curbs chronic inflammation but also staves off tumor growth. While the impact on human longevity remains uncertain, promising trials may soon pave the way for healthier aging.

1 of 1

Story summary

A groundbreaking study by scientists at the Max Planck Institute reveals that a drug cocktail of rapamycin and trametinib significantly boosts mice lifespans by 26-35%. This powerful combination not only curbs chronic inflammation but also staves off tumor growth. While the impact on human longevity remains uncertain, promising trials may soon pave the way for healthier aging.